A new market study, titled “Discover Global Cancer Treatment Drugs Market Upcoming Trends, Growth Drivers and Challenges” has been featured on WiseGuyReports.
Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others.
The classification of cancer treatment drugs includes chemotherapy, targeted therapy, immunotherapy, hormonal therapy and others, and the revenue proportion of chemotherapy in 2016 is about 51%.
Cancer treatment drugs are widely used for blood cancer, breast cancer, gastrointestinal cancer, prostate cancer, respiratory/lung cancer and other cancers. Amongst these different cancer types, blood cancer was the largest revenue generating segment in 2016, and the revenue market share is about 22%. The growth of blood cancer segment is majorly due to the high cost of the drugs used to treat blood cancer.
Europe region is the largest supplier of cancer treatment drugs, with a revenue market share nearly 47% in 2016. North America is the second largest supplier of cancer treatment drugs, enjoying revenue market share nearly 34% in 2016. Japan region is also holding the monopoly position around the world.
North America is the largest consumption place, with the consumption market share nearly 43% in 2016, and North America market size reached 46 billion . China, India and Southeast Asia are the emerging markets, and enjoy higher grow rate.
According to this study, over the next five years the Cancer Treatment Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Cancer Treatment Drugs business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Cancer Treatment Drugs market by product type, application, key manufacturers and key regions and countries.
This study considers the Cancer Treatment Drugs value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Hormonal Therapy (Biologic Therapy)
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Middle East & Africa
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Johnson & Johnson
Merck & Co.
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
To study and analyze the global Cancer Treatment Drugs consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Cancer Treatment Drugs market by identifying its various subsegments.
Focuses on the key global Cancer Treatment Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Cancer Treatment Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Cancer Treatment Drugs submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cancer Treatment Drugs Consumption 2014-2024
2.1.2 Cancer Treatment Drugs Consumption CAGR by Region
2.2 Cancer Treatment Drugs Segment by Type
2.2.2 Targeted Therapy
2.2.4 Hormonal Therapy (Biologic Therapy)
2.3 Cancer Treatment Drugs Consumption by Type
2.3.1 Global Cancer Treatment Drugs Consumption Market Share by Type (2014-2019)
2.3.2 Global Cancer Treatment Drugs Revenue and Market Share by Type (2014-2019)
2.3.3 Global Cancer Treatment Drugs Sale Price by Type (2014-2019)
2.4 Cancer Treatment Drugs Segment by Application
2.4.1 Blood Cancer
2.4.2 Breast Cancer
2.4.3 Gastrointestinal Cancer
2.4.4 Prostate Cancer
2.4.5 Respiratory/Lung Cancer
2.4.6 Other Cancers
2.5 Cancer Treatment Drugs Consumption by Application
2.5.1 Global Cancer Treatment Drugs Consumption Market Share by Application (2014-2019)
2.5.2 Global Cancer Treatment Drugs Value and Market Share by Application (2014-2019)
2.5.3 Global Cancer Treatment Drugs Sale Price by Application (2014-2019)
3 Global Cancer Treatment Drugs by Players
3.1 Global Cancer Treatment Drugs Sales Market Share by Players
3.1.1 Global Cancer Treatment Drugs Sales by Players (2017-2019)
3.1.2 Global Cancer Treatment Drugs Sales Market Share by Players (2017-2019)
3.2 Global Cancer Treatment Drugs Revenue Market Share by Players
3.2.1 Global Cancer Treatment Drugs Revenue by Players (2017-2019)
3.2.2 Global Cancer Treatment Drugs Revenue Market Share by Players (2017-2019)
3.3 Global Cancer Treatment Drugs Sale Price by Players
3.4 Global Cancer Treatment Drugs Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Cancer Treatment Drugs Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Cancer Treatment Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Cancer Treatment Drugs by Regions
4.1 Cancer Treatment Drugs by Regions
4.1.1 Global Cancer Treatment Drugs Consumption by Regions
4.1.2 Global Cancer Treatment Drugs Value by Regions
4.2 Americas Cancer Treatment Drugs Consumption Growth
4.3 APAC Cancer Treatment Drugs Consumption Growth
4.4 Europe Cancer Treatment Drugs Consumption Growth
4.5 Middle East & Africa Cancer Treatment Drugs Consumption Growth
13 Research Findings and Conclusion
List of Tables and Figures
Figure Picture of Cancer Treatment Drugs
Table Product Specifications of Cancer Treatment Drugs
Figure Cancer Treatment Drugs Report Years Considered
Figure Market Research Methodology
Figure Global Cancer Treatment Drugs Consumption Growth Rate 2014-2024 (K Units)
Figure Global Cancer Treatment Drugs Value Growth Rate 2014-2024 ($ Millions)
Table Cancer Treatment Drugs Consumption CAGR by Region 2014-2024 ($ Millions)
Figure Product Picture of Chemotherapy
Table Major Players of Chemotherapy
Figure Product Picture of Targeted Therapy
Table Major Players of Targeted Therapy
Figure Product Picture of Immunotherapy
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)